CTVA(CTVA)
CTVA
Q4 2026 EPS Estimate
$-0.42
Nov 3, 2026 · Reports after close
Revenue Estimate
$2.65B
FY2026E EPS$3.75
FY2027E EPS$4.15
Analyst Sentiment
Wall St. Consensus
Buy28 analysts·High coverage
67
Score
19 Buy (68%)9 Hold (32%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1968%
Hold
932%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$86.00
+5.6%
Consensus
$96.00
+17.9%
Bull
$103.00
+26.5%
12-Month Target Range28 analysts
$86.00$96.00$103.00
Current $81.41Consensus
Current Price
$81.41
Upside to Consensus
$14.59
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.37%
EPS+10.66%
FY2028
Rev+2.74%
EPS+11.13%
FY2029
Rev+0.88%
EPS+11.83%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $18.12B | $18.73B | $19.25B | $19.42B |
| Low | $17.95B | $18.55B | $18.77B | $19.11B |
| High | $18.31B | $19.14B | $19.74B | $19.78B |
| EBITDA Avg | $3.16B | $3.27B | $3.36B | $3.39B |
| Low | $3.13B | $3.24B | $3.28B | $3.34B |
| High | $3.20B | $3.34B | $3.45B | $3.45B |
| EBIT Avg | $1.85B | $1.92B | $1.97B | $1.99B |
| Low | $1.84B | $1.90B | $1.92B | $1.95B |
| High | $1.87B | $1.96B | $2.02B | $2.02B |
| Net Income Avg | $2.53B | $2.71B | $3.14B | $3.52B |
| Low | $2.51B | $2.50B | $3.06B | $3.44B |
| High | $2.61B | $3.04B | $3.23B | $3.60B |
| EPS Avg | $3.75 | $4.15 | $4.62 | $5.16 |
| Low | $3.68 | $3.66 | $4.49 | $5.05 |
| High | $3.82 | $4.45 | $4.74 | $5.29 |
| Analysts (Rev / EPS) | 15 / 11 | 15 / 5 | 12 / 2 | 10 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.65B | $4.17B | $5.06B | $6.63B | $2.84B | $4.46B | $5.22B | $6.95B |
| Low | $2.55B | $4.10B | $4.89B | $6.40B | $2.74B | $4.31B | $5.04B | $6.71B |
| High | $2.76B | $4.28B | $5.26B | $6.89B | $2.95B | $4.64B | $5.43B | $7.23B |
| EBITDA Avg | $463M | $728M | $884M | $1.16B | $496M | $780M | $912M | $1.21B |
| Low | $446M | $716M | $853M | $1.12B | $479M | $753M | $881M | $1.17B |
| High | $483M | $747M | $919M | $1.20B | $515M | $811M | $948M | $1.26B |
| EBIT Avg | $271M | $427M | $518M | $678M | $290M | $457M | $534M | $711M |
| Low | $261M | $419M | $500M | $655M | $280M | $441M | $516M | $687M |
| High | $283M | $438M | $538M | $705M | $302M | $475M | $556M | $739M |
| Net Income Avg | $-262M | $218M | $1.01B | $1.69B | $-210M | $294M | $1.09B | $1.91B |
| Low | $-343M | $173M | $961M | $1.61B | $-220M | $281M | $1.04B | $1.82B |
| High | $-187M | $256M | $1.06B | $1.78B | $-200M | $310M | $1.15B | $2.01B |
| EPS Avg | $-0.39 | $0.32 | $1.50 | $2.51 | $-0.31 | $0.44 | $1.63 | $2.84 |
| Low | $-0.51 | $0.26 | $1.43 | $2.40 | $-0.33 | $0.42 | $1.56 | $2.72 |
| High | $-0.28 | $0.38 | $1.57 | $2.64 | $-0.30 | $0.46 | $1.71 | $2.99 |
| Analysts (Rev / EPS) | 8 / 10 | 8 / 10 | 4 / 8 | 5 / 8 | 4 / 8 | 5 / 8 | 3 / 9 | 4 / 9 |